Skip to main content
SpringerLink
Log in

Genetics of Achondroplasia and Hypochondroplasia

  • Chapter
The Skeleton

  • 242 Accesses

Abstract

Achondroplasia and hypochondroplasia are relatively common skeletal dysplasias characterized by disproportionate short stature, rhizomelic shortening of the limbs, and increased head circumference. Short stature and body disproportion are usually severe and uniform in achondroplasia, whereas phenotype in hypochondroplasia varies from severe achondroplasia-like forms to mild shortness and body disproportion. Mild forms of hypochondroplasia are on clinical grounds difficult to differentiate from idiopathic short stature or normal height at the shorter end of the height spectrum.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hecht, J. T., Thompson, N. M., Weir, T., Patchell, L., and Horton, W. A. (1991) Cognitive and motor skills in achondroplastic infants: neurologic and respiratory correlates. Am. J. Med. Genet. 41, 208–211.

    Article  CAS  PubMed  Google Scholar 

  2. Langer, L. O., Jr., Baumann, P. A., and Gorlin, R. J. (1967) Achondroplasia. Am. J. Roentgenol. Radium Ther. Nucl. Med. 100, 12–26.

    Article  PubMed  Google Scholar 

  3. Scott, C. I. Jr. (1976) Achondroplastic and hypochondroplastic dwarfism. Clin. Orthop. Jan./Feb., 18–30.

    Google Scholar 

  4. Horton, W. A., Rotter, J. I., Kaitila, I., et al. (1977) Growth curves in achondroplasia. Birth Defects Orig. Artic. Ser. 13, 101–107.

    CAS  PubMed  Google Scholar 

  5. Hall, B. D. and Spranger, J. (1979) Hypochondroplasia: clinical and radiological aspects in 39 cases. Radiology 133, 95–100.

    CAS  PubMed  Google Scholar 

  6. Grigelioniene, G., Eklof, O., Laurencikas, E., Ollars, B., Hertel, N. T., Dumanski, J. P., and Hagenas, L. (2000) Asn540Lys mutation in fibroblast growth factor receptor 3 and phenotype in hypochondroplasia. Acta Paediatr. 89, 1072–1076.

    Article  CAS  PubMed  Google Scholar 

  7. Brook, C. G. and de Vries, B. B. (1998) Skeletal dysplasias. Arch. Dis. Child. 79, 285–289.

    Article  CAS  PubMed  Google Scholar 

  8. Appan, S., Laurent, S., Chapman, M., Hindmarsh, P. C., and Brook, C. G. (1990) Growth and growth hormone therapy in hypochondroplasia. Acta Paediatr. Scand. 79, 796–803.

    Article  CAS  PubMed  Google Scholar 

  9. Bridges, N. A., Hindmarsh, P. C., and Brook, C. G. (1991) Growth of children with hypochondroplasia treated with growth hormone for up to three years. Harm. Res. 36, 56–60.

    Article  Google Scholar 

  10. Orioli, I. M., Castilla, E. E., and Barbosa-Neto, J. G. (1986) The birth prevalence rates for the skeletal dysplasias. J. Med. Genet. 23, 328–332.

    Article  CAS  PubMed  Google Scholar 

  11. Martinez-Frias, M. L., Cereijo, A., Bermejo, E., Lopez, M., Sanchez, M., and Gonzalo, C. (1991) Epidemiological aspects of Mendelian syndromes in a Spanish population sample: I. Autosomal dominant malformation syndromes. Am. J. Med. Genet. 38, 622–625.

    Article  CAS  PubMed  Google Scholar 

  12. Bellus, G. A., Hefferon, T. W., Ortiz de Luna, R. I., Hecht, J. T., Horton, W. A., Machado, M., et al. (1995) Achondronlasia is defined by recurrent G380R mutations of FGFR3. Am. J. Hum. Genet. 56, 368–373.

    CAS  PubMed  Google Scholar 

  13. Stoll, C., Roth, M. P., and Bigel, P. (1982) A reexamination on parental age effect on the occurrence of new mutations for achondroplasia. Prog. Clin. Biol. Res. 104, 419–426.

    CAS  PubMed  Google Scholar 

  14. Wilkin, D. J., Szabo, J. K., Cameron, R., Henderson, S., Bellus, G. A., Mack, M. L., et al. (1998) Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. Am. J. Hum. Genet. 63, 711–716.

    Article  CAS  PubMed  Google Scholar 

  15. Bowen, P. (1974) Achondroplasia in two sisters with normal parents. Birth Defects Orig. Artic. Ser. 10, 31–36.

    CAS  PubMed  Google Scholar 

  16. Henderson, S., Sillence, D., Loughlin, J., Bennetts, B., and Sykes, B. (2000) Germline and somatic mosaicism in achondroplasia. J. Med. Genet. 37, 956–958.

    Article  CAS  PubMed  Google Scholar 

  17. McKusick, V. A., Kelly, T. E., and Dorst, J. P. (1973) Observations suggesting allelism of the achondroplasia and hynnchondronlasia genes. I. Med. Genet. 10. 11–16.

    Article  CAS  Google Scholar 

  18. Shiang, R., Thompson, L. M., Zhu, Y. Z., Church, D. M., Fielder, T. J., Bocian, M., et al. (1994) Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78, 335–342.

    Article  CAS  PubMed  Google Scholar 

  19. Bellus, G. A., McIntosh, I., Smith, E. A., Aylsworth, A. S., Kaitila, I., Horton, W. A., et al. (1995) A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nat. Genet. 10, 357–359.

    Article  CAS  PubMed  Google Scholar 

  20. Prinos, P., Costa, T., Sommer, A., Kilpatrick, M. W., and Tsipouras, P. (1995) A common FGFR3 gene mutation in hypochondroplasia. Hum. Mol. Genet. 4, 2097–2101.

    Article  CAS  PubMed  Google Scholar 

  21. Bonaventure, J., Rousseau, F., Legeai-Mallet, L., Le Merrer, M., Munnich, A., and Maroteaux, P. (1996) Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism. Am. J. Med. Genet. 63,148–154.

    Article  CAS  PubMed  Google Scholar 

  22. Rousseau, F., Bonaventure, J., Legeai-Mallet, L., Schmidt, H., Weissenbach, J., Maroteaux, P., et al. (1996) Clinical and genetic heterogeneity of hypochondroplasia. J. Med. Genet. 33,749–752.

    Article  CAS  PubMed  Google Scholar 

  23. Prinster, C., Carrera, P., Del Maschio, M., Weber, G., Maghnie, M., Vigone, M. C., et al. (1998) Comparison of clinical-radiological and molecular findings in hypochondroplasia. Am. J. Med. Genet. 75, 109–112.

    Article  CAS  PubMed  Google Scholar 

  24. Ramaswami, U., Rumsby, G., Hindmarsh, P. C., and Brook, C. G. (1998) Genotype and phenotype in hypochondroplasia. J. Pediatr. 133, 99–102.

    Article  CAS  PubMed  Google Scholar 

  25. Tsai, F. J., Wu, J. Y., Tsai, C. H., and Chang, J. G. (1999) Identification of a common N540K mutation in 8/18 Taiwanese hypochondroplasia patients: further evidence for genetic heterogeneity. Clin. Genet. 55. 279–250.

    Article  CAS  PubMed  Google Scholar 

  26. Stoilov, I., Kilpatrick, M. W., Tsipouras, P., and Costa, T. (1995) Possible genetic heterogeneity in hypochondroplasia. J. Med. Genet. 32, 492–493.

    Article  CAS  PubMed  Google Scholar 

  27. Prinster, C., Del Maschio, M., Beluffi, G., Maghnie, M., Weber, G., Del Maschio, A., et al. (2001) Diagnosis of hypochondroplasia: the role of radiological interpretation. Italian Study Group for Hypochondroplasia. Pediatr. Radiol. 31, 203–208.

    Article  CAS  PubMed  Google Scholar 

  28. Angle, B., Hersh, J. H., and Christensen, K. M. (1998) Molecularly proven hypochondroplasia with cloverleaf skull deformity: a novel association. Clin. Genet. 54, 417–420.

    Article  CAS  PubMed  Google Scholar 

  29. Wuechner, C., Nordqvist, A. C., Winterpacht, A., Zabel, B., and Schalling, M. (1996) Developmental expression of splicing variants of fibroblast growth factor receptor 3 (FGFR3) in mouse. Int. J. Dev. Biol. 40. 1185–1188.

    CAS  PubMed  Google Scholar 

  30. Peters, K., Ornitz, D., Werner, S., and Williams, L. (1993) Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Dev. Biol. 155, 423–430.

    Article  CAS  PubMed  Google Scholar 

  31. Delezoide, A. L., Benoist-Lasselin, C., Legeai-Mallet, L., Le Merrer, M., Munnich, A., Vekemans, M., et al. (1998) Spatio-temporal expression of FGFR 1,2 and 3 genes during human embryo fetal ossification. Mech. Dev. 77. 19–30.

    Article  CAS  PubMed  Google Scholar 

  32. Ornitz, D. (2000) Fibroblast Growth Factors, Chondrogenesis, and Related Clinical Disorders, in Skeletal Growth Factors (Canalis, E., ed.). Lippincott Williams and Wilkins, Philadelphia, pp. 197–209.

    Google Scholar 

  33. Weksler, N. B., Lunstrum, G. P., Reid, E. S., and Horton, W. A. (1999) Differential effects of fibroblast growth factor (FGF) 9 and FGF2 on proliferation, differentiation and terminal differentiation of chondrocytic cells in vitro. Biocherm. J. 342, 677–682.

    Article  CAS  Google Scholar 

  34. Tavormina, P. L., Shiang, R., Thompson, L. M., Zhu, Y. Z., Wilkin, D. J., Lachman, R. S., et al. (1995) Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat. Genet. 9. 321–328.

    Article  CAS  PubMed  Google Scholar 

  35. Burke, D., Wilkes, D., Blundell, T. L., and Malcolm, S. (1998) Fibroblast growth factor receptors: lessons from the genes. Trends Biochem. Sci. 23. 59–62.

    Article  CAS  PubMed  Google Scholar 

  36. Bellus, G. A., Bamshad, M. J., Przylepa, K. A., Dorst, J., Lee, R. R., Hurko, O., et al. (1999) Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3. Am. J. Med. Genet. 85, 53–65.

    Article  CAS  PubMed  Google Scholar 

  37. Vajo, Z., Francomano, C. A., and Wilkin, D. J. (2000) The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans. Endocr. Rev. 21. 23–39.

    Article  CAS  PubMed  Google Scholar 

  38. Colvin, J. S., Bohne, B. A., Harding, G. W., McEwen, D. G., and Ornitz, D. M. (1996) Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat. Genet. 12, 390–397.

    Article  CAS  PubMed  Google Scholar 

  39. Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A., and Leder, P. (1996) Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84, 911–921.

    Article  CAS  PubMed  Google Scholar 

  40. Webster, M. K. and Donoghue, D. J. (1996) Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J. 15, 520–527.

    CAS  PubMed  Google Scholar 

  41. Naski, M. C., Wang, Q., Xu, J., and Ornitz, D. M. (1996) Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat. Genet. 13, 233–237.

    Article  CAS  PubMed  Google Scholar 

  42. Raffioni, S., Zhu, Y. Z., Bradshaw, R. A., and Thompson, L. M. (1998) Effect of transmembrane and kinase domain mutations on fibroblast growth factor receptor 3 chimera signaling in PC12 cells. A model for the control of receptor tyrosine kinase activation. J. Biol. Chem. 273. 35250–35259

    Article  CAS  PubMed  Google Scholar 

  43. Bellus, G. A., Spector, E. B., Speiser, P. W., Weaver, C. A., Garber, A. T., Bryke, C. R., et al. (2000) Distinct missense mutations of the FGFR3 1ys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype. Am. J. Hum. Genet. 67. 1411–1421.

    Article  CAS  PubMed  Google Scholar 

  44. Chen, L., Adar, R., Yang, X., Monsonego, E. O., Li, C., Hauschka, P. V., et al. (1999) Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis. J. Clin. Invest. 104, 1517–1525.

    Article  CAS  PubMed  Google Scholar 

  45. Monsonego-Ornan, E., Adar, R., Feferman, T., Segev, O., and Yayon, A. (2000) The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from downregulation. Mol. Cell. Biol. 20, 516–522.

    Article  CAS  PubMed  Google Scholar 

  46. Delezoide, A. L., Lasselin-Benoist, C., Legeai-Mallet, L., Brice, P., Senee, V., Yayon, A., et al. (1997) Abnormal FGFR 3 expression in cartilage of thanatophoric dysplasia fetuses. Hum. Mol. Genet. 6, 1899–1906.

    Article  CAS  PubMed  Google Scholar 

  47. Naski, M. C., Colvin, J. S., Coffin, J. D., and Ornitz, D. M. (1998) Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Development 125, 4977–4988.

    CAS  PubMed  Google Scholar 

  48. Li, C., Chen, L., Iwata, T., Kitagawa, M., Fu, X. Y., and Deng, C. X. (1999) A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors. Hum. Mol. Genet. 8, 35–44.

    Article  CAS  PubMed  Google Scholar 

  49. Wang, Y., Spatz, M. K., Kannan, K., Hayk, H., Avivi, A., Gorivodsky, M., et al. (1999) A mouse model for achondronlasia produced by targeting fibroblast growth factor receptor 3. Proc. Natl. Acad. Sci. USA 96, 4455–4460.

    Article  CAS  PubMed  Google Scholar 

  50. Iwata, T., Chen, L., Li, C., Ovchinnikov, D. A., Behringer, R. R., Francomano, C. A., et al. (2000) A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos. Hum. Mol. Genet. 9, 1603–1613.

    Article  CAS  PubMed  Google Scholar 

  51. Segev, O., Chumakov, I., Nevo, Z., Givol, D., Madar-Shapiro, L., Sheinin, Y., et al. (2000) Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3(G380R) transgenic mice. Hum. Mol. Genet. 9, 249–258.

    Article  CAS  PubMed  Google Scholar 

  52. Rimoin, D. L. (1975) The chondrodystrophies. Adv. Hum. Genet. 5, 1–118.

    Article  CAS  PubMed  Google Scholar 

  53. Legeai-Mallet, L., Benoist-Lasselin, C., Delezoide, A. L., Munnich, A., and Bonaventure, J. (1998) Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia. J. Biol. Chem. 273, 13007–13014.

    Article  CAS  PubMed  Google Scholar 

  54. Shimizu, A., Tada, K., Shukunami, C., Hiraki, Y., Kurokawa, T., Magane, N., and Kurokawa-Seo, M. (2001) A novel alternatively spliced fibroblast growth factor receptor 3 isoform lacking the acid box domain is expressed during chondrogenic differentiation of ATDC5 cells. J. Biol. Chem. 276, 11031–11040.

    Article  CAS  PubMed  Google Scholar 

  55. Su, W. C., Kitagawa, M., Xue, N., Xie, B., Garofalo, S., Cho, J., et al. (1997) Activation of Stat 1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature 386, 288–292.

    Article  CAS  PubMed  Google Scholar 

  56. Bi, W., Deng, J. M., Zhang, Z., Behringer, R. R., and de Crombrugghe, B. (1999) Sox9 is required for cartilage tormation. Nat. Genet. 22, 85–89.

    Article  CAS  PubMed  Google Scholar 

  57. Huang, W., Chung, U. I., Kronenberg, H. M., and de Crombrugghe, B. (2001) The chondrogenic transcription factor Sox9 is a target of signaling by the parathyroid hormone-related peptide in the growth plate of endochondral bones. Proc. Natl. Acad. Sci. USA 98, 160–165.

    Article  CAS  PubMed  Google Scholar 

  58. Murakami, S., Kan, M., McKeehan, W. L., and de Crombrugghe, B. (2000) Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway. Proc. Natl. Acad. Sci. USA 97, 1113–1118.

    Article  CAS  PubMed  Google Scholar 

  59. Karp, S. J., Schipani, E., St-Jacques, B., Hunzelman, J., Kronenberg, H., and McMahon, A. P. (2000) Indian hedgehog coordinates endochondral bone growth and morphogenesis via parathyroid hormone related-protein-dependent and -independent pathways. Development 127, 543–548.

    CAS  PubMed  Google Scholar 

  60. Henderson, J. E., Naski, M. C., Aarts, M. M., Wang, D., Cheng, L., Goltzman, D., and Ornitz, D. M. (2000) Expression of FGFR3 with the G380R achondroplasia mutation inhibits proliferation and maturation of CFK2 chondrocytic cells. J. Bone Miner. Res. 15, 155–165.

    Article  CAS  PubMed  Google Scholar 

  61. Ikegawa, S., Fukushima, Y., Isomura, M., Takada, F., and Nakamura, Y. (1995) Mutations of the fibroblast growth factor receptor-3 gene in one familial and six sporadic cases of achondroplasia in Japanese patients. Hum. Genet. 96, 309–311.

    Article  CAS  PubMed  Google Scholar 

  62. Superti-Furga, A., Eich, G., Bucher, H. U., Wisser, J., Giedion, A., Gitzelmann, R., et al. (1995) A glycine 375-tocysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondronlasia. Eur. J. Pediatr. 154, 215–219.

    Article  CAS  PubMed  Google Scholar 

  63. Winterpacht, A., Hilbert, K., Stelzer, C., Schweikardt, T., Decker, H., Segerer, H., et al. (2000) A novel mutation in FGFR-3 disrupts a putative N-glycosylation site and results in hypochondroplasia. Physiol. Genomics 2, 9–12.

    CAS  PubMed  Google Scholar 

  64. Grigelioniene, G., Hagenas, L., Eklof, O., Neumeyer, L., Haereid, P. E., and Anvret, M. (1998) A novel missense mutation Ile538Val in the fibroblast growth factor receptor 3 in hypochondroplasia. Mutations in brief no. 122. Online. Hum. Mutat. 11. 333.

    Article  CAS  PubMed  Google Scholar 

  65. Mortier, G., Nuytinck, L., Craen, M., Renard, J. P., Leroy, J. G., and de Paepe, A. (2000) Clinical and radiographic features of a family with hypochondroplasia owing to a novel Asn540Ser mutation in the fibroblast growth factor receptor gene J MM ed Genet. 37. 220–224.

    CAS  Google Scholar 

  66. Deutz-Terlouw, P. P., Losekoot, M., Aalfs, C. M., Hennekam, R. C., and Bakker, E. (1998) Asn540Thr substitution in the fibroblast growth factor receptor 3 tyrosine kinase domain causing hypochondroplasia. Hum. Mutat. Suppl 1, S62–S65.

    Article  PubMed  Google Scholar 

Download references

Authors
  1. Giedre Grigelioniene
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Developmental Biology Branch, Reproductive Toxicology Division, The National Health and Environmental Effects Research Laboratory, Office of Research Development, United States Environmental Protection Agency, Research Triangle Park, NC, USA

    Edward J. Massaro  & John M. Rogers  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media New York

About this chapter

Cite this chapter

Grigelioniene, G. (2004). Genetics of Achondroplasia and Hypochondroplasia. In: Massaro, E.J., Rogers, J.M. (eds) The Skeleton. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-736-9_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-736-9_23

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-427-2

  • Online ISBN: 978-1-59259-736-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation